Lazard Asset Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16M Buy
372,600
+49,101
+15% +$2.11M 0.03% 359
2025
Q4
$14.2M Buy
323,499
+26,064
+9% +$1.08M 0.02% 371
2025
Q3
$12.3M Buy
297,435
+35,218
+13% +$1.42M 0.02% 387
2025
Q2
$11.6M Buy
262,217
+7,419
+3% +$297K 0.02% 516
2025
Q1
$9.41M Buy
254,798
+40,336
+19% +$1.44M 0.01% 503
2024
Q4
$7.14M Buy
214,462
+95,315
+80% +$3.09M 0.01% 549
2024
Q3
$3.09M Buy
119,147
+61,974
+108% +$1.54M ﹤0.01% 756
2024
Q2
$1.28M Buy
57,173
+19,618
+52% +$435K ﹤0.01% 925
2024
Q1
$890K Buy
37,555
+7,891
+27% +$175K ﹤0.01% 945
2023
Q4
$711K Buy
29,664
+4,799
+19% +$104K ﹤0.01% 1024
2023
Q3
$543K Buy
24,865
+6,364
+34% +$133K ﹤0.01% 1127
2023
Q2
$352K Buy
18,501
+1,909
+12% +$36.8K ﹤0.01% 1198
2023
Q1
$322K Buy
16,592
+511
+3% +$8.9K ﹤0.01% 1202
2022
Q4
$257K Sell
16,081
-612
-4% -$9.98K ﹤0.01% 1254
2022
Q3
$261K Buy
16,693
+5,473
+49% +$106K ﹤0.01% 1217
2022
Q2
$233K Sell
11,220
-418,079
-97% -$8.62M ﹤0.01% 1238
2022
Q1
$9.73M Sell
429,299
-2,436,648
-85% -$47.6M 0.01% 624
2021
Q4
$52.4M Buy
2,865,947
+77,752
+3% +$1.49M 0.06% 279
2021
Q3
$58.9M Buy
2,788,195
+746,597
+37% +$13.9M 0.07% 250
2021
Q2
$37.2M Sell
2,041,598
-28,389
-1% -$662K 0.04% 340
2021
Q1
$46.8M Buy
2,069,987
+605,381
+41% +$13.7M 0.06% 263
2020
Q4
$29.4M Buy
1,464,606
+289,840
+25% +$6.07M 0.04% 355
2020
Q3
$28.7M Buy
1,174,766
+99,485
+9% +$2.32M 0.04% 334
2020
Q2
$25.5M Buy
1,075,281
+764,095
+246% +$17.7M 0.04% 333
2020
Q1
$5.36M Buy
311,186
+1,864
+0.6% +$34.1K 0.01% 533
2019
Q4
$5.45M Buy
309,322
+104,971
+51% +$1.78M 0.01% 551
2019
Q3
$3.61M Buy
204,351
+50,521
+33% +$1.02M 0.01% 589
2019
Q2
$3.29M Sell
153,830
-18,010
-10% -$377K 0.01% 668
2019
Q1
$4.09M Sell
171,840
-51,595
-23% -$1.18M 0.01% 626
2018
Q4
$4.39M Sell
223,435
-22,480
-9% -$401K 0.01% 557
2018
Q3
$4.36M Buy
245,915
+13,795
+6% +$269K 0.01% 592
2018
Q2
$5M Buy
+232,120
New +$4.8M 0.01% 566
2016
Q3
Sell
-323,687
Closed -$2.53M 1008
2016
Q2
$2.53M Sell
323,687
-2,342,162
-88% -$13.5M 0.01% 597
2016
Q1
$10.7M Buy
2,665,849
+1,492,107
+127% +$6.32M 0.02% 366
2015
Q4
$6.62M Buy
1,173,742
+754,940
+180% +$4.22M 0.02% 473
2015
Q3
$2.35M Sell
418,802
-1,097,597
-72% -$5.97M 0.01% 582
2015
Q2
$5.7M Buy
1,516,399
+1,214,241
+402% +$3.95M 0.01% 498
2015
Q1
$776K Buy
302,158
+10,464
+4% +$24.3K ﹤0.01% 717
2014
Q4
$420K Hold
291,694
﹤0.01% 838
2014
Q3
$446K Sell
291,694
-34,163
-10% -$110K ﹤0.01% 759
2014
Q2
$1.1M Hold
325,857
﹤0.01% 704
2014
Q1
$1.15M Buy
325,857
+132,836
+69% +$904K ﹤0.01% 664
2013
Q4
$1.18M Sell
193,021
-62,810
-25% -$346K ﹤0.01% 691
2013
Q3
$1.49M Buy
255,831
+134,010
+110% +$694K ﹤0.01% 638
2013
Q2
$553K Buy
+121,821
New +$577K ﹤0.01% 755

Other funds holding EXEL

Lazard Asset Management's EXEL Position: Q1 2026 in Review

Lazard Asset Management increased its Exelixis (EXEL) stake by 15% in Q1 2026, buying an estimated $2.11M and bringing the position to 372,600 shares worth $16M. The position accounts for 0.03% of the portfolio, ranked #359.

Lazard Asset Management first reported a position in EXEL in Q2 2013 and has held it in 45 quarters since. The position peaked at $58.9M in Q3 2021. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Lazard Asset Management held 372,600 shares of Exelixis worth $16M as of Q1 2026.
  • Lazard Asset Management bought 49,101 Exelixis shares in Q1 2026, an estimated $2.11M.
  • Exelixis made up 0.03% of Lazard Asset Management's portfolio in Q1 2026, its #359 holding.
  • Lazard Asset Management first reported a position in Exelixis in Q2 2013 and has held it in 45 quarters since.
  • Lazard Asset Management's Exelixis position peaked at $58.9M in Q3 2021.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.